XML 34 R19.htm IDEA: XBRL DOCUMENT

SHARE CAPITAL AND STOCK OPTIONS (Tables)

6 Months Ended

Dec. 31, 2012

Stockholders Equity Note [Line Items]

	Six months ended December 31, 2012
	Number			Weighted Average Exercise Price		Weighted Average Remaining Contractual Terms (in years)		Aggregate Intrinsic Value Price
Options outstanding at beginning of period		2,082,172		$	3.87
Options exercised		(74,332	)		1.57
Options outstanding at end of the period		2,007,840		$	3.95		4.47	$	1,227
Options exercisable at the end of the period		2,007,840		$	3.95		4.47	$	1,227
Options vested		2,007,840		$	3.95		4.47	$	1,227

Schedule of Options and Warrants

	Six months ended December 31, 2012
	Number			Weighted Average Exercise Price		Weighted Average Remaining Contractual Terms (in years)		Aggregate Intrinsic Value Price
Options and warrants outstanding at beginning of period		382,000		$	3.86
Options and warrants exercised		(63,500	)		1.18
Options and warrants outstanding at end of the period		318,500		$	4.40		4.56	$	459

Options and warrants exercisable at the end of the period		309,500		$	4.52		4.44	$	430

Options and warrants vested		318,500		$	4.40		4.56	$	459

Schedule of Unvested Restricted Stock Units, Consultants

	Number
Unvested at the beginning of period		66,000
Granted		88,206
Forfeited		(21,978	)
Vested		(129,228	)
Unvested at the end of the period		3,000
Expected to vest after December 31, 2012		3,000

Schedule of Unvested Restricted Stock Units, Employees and Directors

	Number
Unvested at the beginning of period		2,085,276
Granted		13,000
Forfeited		(77,963	)
Vested		(979,175	)
Unvested at the end of the period		1,041,138
Expected to vest after December 31, 2012		1,023,172

Options and Warrants [Member]

Stockholders Equity Note [Line Items]

Schedule of Stock-based Compensation Expenses Recognized

	Six months ended December 31,				Three months ended December 31,
	2012		2011		2012		2011
Research and development expenses	$	-	$	19	$	-	$	9
General and administrative expenses		21		15		3		7
	$	21	$	34	$	3	$	16

Restricted Stock and Restricted Stock Units [Member]

Stockholders Equity Note [Line Items]

Schedule of Stock-based Compensation Expenses Recognized

	Six months ended December 31,				Three months ended December 31,
	2012		2011		2012		2011
Research and development expenses	$	481	$	483	$	164	$	230
General and administrative expenses		1,028		1,290		420		612
	$	1,509	$	1,773	$	584	$	842

Consultant Restricted Stock Units And Restricted Stock [Member]

Stockholders Equity Note [Line Items]

Schedule of Stock-based Compensation Expenses Recognized

	Six months ended December 31,				Three months ended December 31,
	2012		2011		2012		2011
Research and development expenses	$	154	$	112	$	34	$	53
General and administrative expenses		278		1		5		1
	$	432	$	113	$	39	$	54

- Definition

Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.

+ References+ Details

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References+ Details